Ipca Laboratories informs about disclosure

07 Feb 2026 Evaluate
Ipca Laboratories has informed that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, they had vide letter dated 5th December, 2025, intimated about US FDA inspection of Company’s Active Pharmaceutical Ingredients (API) manufacturing facility situated at Tarapur (Palghar-Maharashtra) from 1st December, 2025 to 5th December, 2025. This manufacturing facility has now received Establishment Inspection Report classifying the manufacturing facility as Voluntary Action Indicated (VAI) and that this facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP).

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1424.25 -20.40 (-1.41%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×